ZCM
CASI

Zebra Capital Management’s CASI Pharmaceuticals CASI Stock Holding History

Zebra Capital Management’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,118
Closed -$33K – 180
2020
Q4 		$33K Hold
1,118
– – 0.04% 162
2020
Q3 		$17K Sell
1,118
-3,948
-78% -$74.4K 0.03% 164
2020
Q2 		$127K Sell
5,066
-186
-4% -$4.04K 0.18% 183
2020
Q1 		$107K Buy
5,252
+823
+19% +$19.6K 0.17% 179
2019
Q4 		$137K Buy
+4,429
New +$144K 0.12% 251

Other funds holding CASI

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
IACGFIA
IDG-Accel China Growth Fund III Associates Hong Kong $31.2M AUM 2.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return
WSC
Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return
TLP
Tri Locum Partners New York $713M AUM 68.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return